Multi-Omics Analysis in the Study of Carcinogenesis
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: 15 September 2025 | Viewed by 1148
Special Issue Editor
Interests: obesity; cytokine; diabetes; breast cancer; steroid
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Multi-omics analyses have been established as powerful tools in investigating carcinogenesis, offering a broad view of the molecular mechanisms underlying cancer initiation and progression. The importance of integrating data obtained from multi-omics analyses with data derived from single-omics methods has been widely acknowledged. Correlating datasets from genomics, transcriptomics, proteomics, and metabolomics with clinical practice observations has proven to be a powerful approach to distinguishing different subtypes of patients within a population, as well as in the search for novel drug targets. In addition, the use of machine and deep learning in multi-omics data analyses is promising for the future development of oncology research.
This Special Issue welcomes the submission of a broad range of research and review manuscripts investigating the implications of multi-omics analysis in oncology research. We believe that such a group of articles will benefit basic science and clinical research scientists by providing a valuable summary of knowledge from various disciplines.
Dr. Dimiter Avtanski
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- carcinogenesis
- cancer initiation and progression
- oncology research
- multi-omics analyses
- genomics
- transcriptomics, proteomics
- metabolomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
